Advisory Committee on the Medical Uses of Isotopes: Charter Renewal, 12207-12208 [2022-04463]

Download as PDF Federal Register / Vol. 87, No. 42 / Thursday, March 3, 2022 / Notices You may join by phone by dialing toll number 1–929–251–9612 or 1–415–527– 5035, both days. The agenda for the meeting includes the following topics: —Astrophysics Division Update —Updates on Specific Astrophysics Missions —Reports from the Program Analysis Groups The agenda will be posted on the Astrophysics Advisory Committee web page: https://science.nasa.gov/ researchers/nac/science-advisorycommittees/apac. The public may submit and upvote comments/questions ahead of the meeting through the website https:// nasa.cnf.io/sessions/cde7/#!/dashboard that will be opened for input on March 15, 2022. It is imperative that the meeting be held on this date to accommodate the scheduling priorities of the key participants. Patricia Rausch, Advisory Committee Management Officer, National Aeronautics and Space Administration. BILLING CODE 7510–13–P NATIONAL SCIENCE FOUNDATION khammond on DSKJM1Z7X2PROD with NOTICES Advisory Committee for Mathematical and Physical Sciences; Notice of Meeting In accordance with the Federal Advisory Committee Act (Pub. L. 92– 463, as amended), the National Science Foundation (NSF) announces the following meeting: Name and Committee Code: Advisory Committee for Mathematical and Physical Sciences (#66). Date and Time: March 29, 2022; 12:00 p.m. to 5:00 p.m. March 30, 2022: 12:05 p.m. to 4:45 p.m. Place: NSF, 2415 Eisenhower Avenue, Alexandria, VA 22314 (Virtual attendance only). To attend the virtual meeting, please send your request for the virtual meeting link to Michelle Bushey at the following email address: mbushey@nsf.gov. Type of Meeting: Open. Contact Person: Leighann Martin, National Science Foundation, 2415 Eisenhower Avenue, Room C 9000, Alexandria, Virginia 22314; Telephone: 703/292–4659. Summary of Minutes: Minutes and meeting materials will be available on the MPS Advisory Committee website at https://www.nsf.gov/mps/advisory.jsp or can be obtained from the contact person listed above. 18:23 Mar 02, 2022 Jkt 256001 Agenda Tuesday, March 29, 2022 • Call to Order and Official Opening of the Meeting • Approval of Prior Meeting Minutes— Catherine Hunt, MPSAC Chair • MPS Update by Assistant Director • Science Highlight • MPS and the Living World Subcommittee Report—AC Vote • MPS Facilities Portfolio Overview and Discussion • MPS AC Subcomittee on Facilities and Infrastructrure—AC Vote • MPS AC Subcommittee on Facilities and Infrastructure—Charge 2 • CEOSE Updates • Preparation for discussion with NSF Director and COO • Closing remarks and adjourn day 1 Wednesday. March 30, 2022 [FR Doc. 2022–04440 Filed 3–2–22; 8:45 am] VerDate Sep<11>2014 Purpose of Meeting: To provide advice, recommendations and counsel on major goals and policies pertaining to MPS programs and activities. • Welcome and overview of agenda • Science Highlight • Environmental Research and Education (ERE) AC Outbrief and Panel • Measuring MPS Impact • Preparation for discussion with NSF Director and COO • Meeting and discussion with NSF Director and COO • Closing remarks and adjourn Dated: February 25, 2022. Crystal Robinson, Committee Management Officer. 12207 Agenda I. Call to Order II. FY21 External Audit—BDO III. Sunshine Act Approval of Executive (Closed) Session IV. Executive Session with External Auditors—BDO V. Executive Session with Chief Audit Executive VI. Action Item Approval of FY21 External Audit VII. Action Item HPN Launchpad Acquisition Audit Report VIII. Internal Audit Status Reports a. Internal Audit Reports Awaiting Management’s Response Æ Finance—Accounts Payable/ACH Transactions (NetSuite) FY21 b. ITS Road Map IAM Dependency c. Internal Audit Performance Scorecard d. Implementation of Internal Audit Recommendations IX. Adjournment CONTACT PERSON FOR MORE INFORMATION: Lakeyia Thompson, Special Assistant, (202) 524–9940; Lthompson@nw.org. Lakeyia Thompson, Special Assistant. [FR Doc. 2022–04604 Filed 3–1–22; 11:15 am] BILLING CODE 7570–02–P NUCLEAR REGULATORY COMMISSION Advisory Committee on the Medical Uses of Isotopes: Charter Renewal U.S. Nuclear Regulatory Commission. ACTION: Notice of charter renewal. AGENCY: [FR Doc. 2022–04414 Filed 3–2–22; 8:45 am] BILLING CODE 7555–01–P The U.S. Nuclear Regulatory Commission (NRC) has determined that renewal of the charter for the Advisory Committee of the Medical Uses of Isotopes (ACMUI) until February 28, 2024, is in the public interest in connection with duties imposed on the Commission by law. This action is being taken in accordance with the Federal Advisory Committee Act, after consultation with the Committee Management Secretariat, General Services Administration. FOR FURTHER INFORMATION CONTACT: Donald Lowman, Office of Nuclear Material Safety and Safeguards, U.S. Nuclear Regulatory Commission, Washington, DC 20555; Telephone: (301) 415–5452 or at Donald.Lowman@ nrc.gov. SUPPLEMENTARY INFORMATION: The purpose of the ACMUI is to provide advice to the NRC on policy and technical issues that arise in regulating SUMMARY: NEIGHBORHOOD REINVESTMENT CORPORATION Sunshine Act Meetings; Audit Committee Meeting 2:00 p.m., Thursday, March 10, 2022. PLACE: Via Conference Call. STATUS: Parts of this meeting will be open to the public. The rest of the meeting will be closed to the public. MATTERS TO BE CONSIDERED: Audit Committee Meeting. The General Counsel of the Corporation has certified that in his opinion, one or more of the exemptions set forth in the Government in the Sunshine Act, 5 U.S.C. 552b(c)(2) and (4) permit closure of the following portion(s) of this meeting: • Executive Session TIME AND DATE: PO 00000 Frm 00134 Fmt 4703 Sfmt 4703 E:\FR\FM\03MRN1.SGM 03MRN1 12208 Federal Register / Vol. 87, No. 42 / Thursday, March 3, 2022 / Notices the medical use of byproduct material for diagnosis and therapy. Responsibilities include providing guidance and comments on current and proposed NRC regulations and regulatory guidance concerning medical use; evaluating certain non-routine uses of byproduct material for medical use; and evaluating training and experience of proposed authorized users. The members are involved in preliminary discussions of major issues in determining the need for changes in NRC policy and regulation to ensure the continued safe use of byproduct material. Each member provides technical assistance in his/her specific area(s) of expertise, particularly with respect to emerging technologies. Members also provide guidance as to NRC’s role in relation to the responsibilities of other Federal agencies as well as of various professional organizations and boards. Members of this Committee have demonstrated professional qualifications and expertise in both scientific and non-scientific disciplines including nuclear medicine; nuclear cardiology; radiation therapy; medical physics; nuclear pharmacy; State medical regulation; patient’s rights and care; health care administration; and Food and Drug Administration regulation. Dated at Rockville, Maryland, this 28th day of February, 2022. For the U.S. Nuclear Regulatory Commission. Russell E. Chazell, Federal Advisory Committee Management Officer. [FR Doc. 2022–04463 Filed 3–2–22; 8:45 am] BILLING CODE 7590–01–P NUCLEAR REGULATORY COMMISSION [NRC–2021–0143] Cyber Security Programs for Nuclear Power Reactors Nuclear Regulatory Commission. ACTION: Draft regulatory guide; request for comment. AGENCY: The U.S. Nuclear Regulatory Commission (NRC) is issuing for public comment a draft regulatory guide (DG), DG–5061, Revision 1, ‘‘Cyber Security Programs for Nuclear Power Reactors.’’ DG 5061, Revision 1, incorporates reference to industry whitepapers on identifying safety, important to safety, balance of plant, and emergency preparedness Critical Digital Assets. It khammond on DSKJM1Z7X2PROD with NOTICES SUMMARY: VerDate Sep<11>2014 18:23 Mar 02, 2022 Jkt 256001 also clarifies guidance on defense-indepth for cyber security and includes updated text based on the latest National Institute of Standards and Technology (NIST) and International Atomic Energy Agency cyber security guidance. Specifically, this proposed revision clarifies issues identified from cyber security inspections, insights gained through the Security Frequently Asked Questions (SFAQ) process, documented cyber security attacks, new technologies, and new regulations. This proposed revision also considers the changes in the most recent revision to the NIST Special Publications (SP) 800– 53, upon which Revision 0 of Regulatory Guide (RG) 5.71, ‘‘Cyber Security Programs for Nuclear Facilities’’ was based. Submit comments by May 2, 2022. Comments received after this date will be considered if it is practical to do so, but the NRC is able to ensure consideration only for comments received on or before this date. DATES: You may submit comments by any of the following methods; however, the NRC encourages electronic comment submission through the Federal Rulemaking Website: • Federal Rulemaking Website: Go to https://www.regulations.gov and search for Docket ID NRC–2021–0143. Address questions about Docket IDs in Regulations.gov to Stacy Schumann; telephone: 301–415–0624; email: Stacy.Schumann@nrc.gov. For technical questions, contact the individuals listed in the FOR FURTHER INFORMATION CONTACT section of this document. • Mail comments to: Office of Administration, Mail Stop: TWFN–7– A60M, U.S. Nuclear Regulatory Commission, Washington, DC 20555– 0001, ATTN: Program Management, Announcements and Editing Staff. For additional direction on obtaining information and submitting comments, see ‘‘Obtaining Information and Submitting Comments’’ in the SUPPLEMENTARY INFORMATION section of this document. ADDRESSES: Kim Lawson-Jenkins, Office of Nuclear Security and Incident Response, telephone: 301–287–3656, email: Kim.Lawson-Jenkins@nrc.gov and Mekonen Bayssie, Office of Nuclear Regulatory Research, telephone: 301– 415–1699, email: Mekonen.Bayssie@ nrc.gov. Both are staff of the U.S. Nuclear Regulatory Commission, Washington, DC 20555–0001. FOR FURTHER INFORMATION CONTACT: SUPPLEMENTARY INFORMATION: PO 00000 Frm 00135 Fmt 4703 Sfmt 4703 I. Obtaining Information and Submitting Comments A. Obtaining Information Please refer to Docket ID NRC–2021– 0143 when contacting the NRC about the availability of information for this action. You may obtain publicly available information related to this action by any of the following methods: • Federal Rulemaking Website: Go to https://www.regulations.gov and search for Docket ID NRC–2021–0143. • NRC’s Agencywide Documents Access and Management System (ADAMS): You may obtain publicly available documents online in the ADAMS Public Documents collection at https://www.nrc.gov/reading-rm/ adams.html. To begin the search, select ‘‘Begin Web-based ADAMS Search.’’ For problems with ADAMS, please contact the NRC’s Public Document Room (PDR) reference staff at 1–800–397–4209, 301– 415–4737, or by email to PDR.Resource@nrc.gov. The ADAMS accession number for each document referenced (if it is available in ADAMS) is provided the first time that it is mentioned in this document. • NRC’s PDR: You may examine and purchase copies of public documents, by appointment, at the NRC’s PDR, Room P1 B35, One White Flint North, 11555 Rockville Pike, Rockville, Maryland 20852. To make an appointment to visit the PDR, please send an email to PDR.Resource@nrc.gov or call 1–800–397–4209 or 301–415– 4737, between 8:00 a.m. and 4:00 p.m. (ET), Monday through Friday, except Federal holidays. B. Submitting Comments The NRC encourages electronic comment submission through the Federal Rulemaking Website (https:// www.regulations.gov). Please include Docket ID NRC–2021–0143 in your comment submission. The NRC cautions you not to include identifying or contact information that you do not want to be publicly disclosed in your comment submission. The NRC will post all comment submissions at https:// www.regulations.gov as well as enter the comment submissions into ADAMS. The NRC does not routinely edit comment submissions to remove identifying or contact information. If you are requesting or aggregating comments from other persons for submission to the NRC, then you should inform those persons not to include identifying or contact information that they do not want to be publicly disclosed in their comment submission. Your request should state that the NRC E:\FR\FM\03MRN1.SGM 03MRN1

Agencies

[Federal Register Volume 87, Number 42 (Thursday, March 3, 2022)]
[Notices]
[Pages 12207-12208]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-04463]


=======================================================================
-----------------------------------------------------------------------

NUCLEAR REGULATORY COMMISSION


Advisory Committee on the Medical Uses of Isotopes: Charter 
Renewal

AGENCY: U.S. Nuclear Regulatory Commission.

ACTION: Notice of charter renewal.

-----------------------------------------------------------------------

SUMMARY: The U.S. Nuclear Regulatory Commission (NRC) has determined 
that renewal of the charter for the Advisory Committee of the Medical 
Uses of Isotopes (ACMUI) until February 28, 2024, is in the public 
interest in connection with duties imposed on the Commission by law. 
This action is being taken in accordance with the Federal Advisory 
Committee Act, after consultation with the Committee Management 
Secretariat, General Services Administration.

FOR FURTHER INFORMATION CONTACT: Donald Lowman, Office of Nuclear 
Material Safety and Safeguards, U.S. Nuclear Regulatory Commission, 
Washington, DC 20555; Telephone: (301) 415-5452 or at 
[email protected].

SUPPLEMENTARY INFORMATION: The purpose of the ACMUI is to provide 
advice to the NRC on policy and technical issues that arise in 
regulating

[[Page 12208]]

the medical use of byproduct material for diagnosis and therapy. 
Responsibilities include providing guidance and comments on current and 
proposed NRC regulations and regulatory guidance concerning medical 
use; evaluating certain non-routine uses of byproduct material for 
medical use; and evaluating training and experience of proposed 
authorized users. The members are involved in preliminary discussions 
of major issues in determining the need for changes in NRC policy and 
regulation to ensure the continued safe use of byproduct material. Each 
member provides technical assistance in his/her specific area(s) of 
expertise, particularly with respect to emerging technologies. Members 
also provide guidance as to NRC's role in relation to the 
responsibilities of other Federal agencies as well as of various 
professional organizations and boards.
    Members of this Committee have demonstrated professional 
qualifications and expertise in both scientific and non-scientific 
disciplines including nuclear medicine; nuclear cardiology; radiation 
therapy; medical physics; nuclear pharmacy; State medical regulation; 
patient's rights and care; health care administration; and Food and 
Drug Administration regulation.

    Dated at Rockville, Maryland, this 28th day of February, 2022.

    For the U.S. Nuclear Regulatory Commission.
Russell E. Chazell,
Federal Advisory Committee Management Officer.
[FR Doc. 2022-04463 Filed 3-2-22; 8:45 am]
BILLING CODE 7590-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.